Find uplifting stories about heroes, innovations, and solutions
5 results for "obesity drugs"
New research reveals genetic variants that explain why weight-loss drugs like semaglutide help some people lose 25% of their body weight while others see minimal results. The discovery could pave the way for more personalized treatments.
Scientists discovered a molecule from python blood that helps obese mice lose 9% of their weight in 28 days, without the stomach problems linked to current obesity drugs. The breakthrough could lead to a new generation of weight-loss treatments inspired by how pythons digest massive meals.
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
Eli Lilly is building a $3.5 billion manufacturing facility in Pennsylvania to produce breakthrough obesity treatments, including an experimental drug showing record-breaking weight loss results. The plant will create 850 permanent jobs and 2,000 construction positions when it opens in 2031.